Document Detail

Maternal and Umbilical Cord Levels of T4, FT4, TSH, TPOAb, and TgAb in Term Infants and Neurodevelopmental Outcome at 5.5 Years.
MedLine Citation:
PMID:  23322817     Owner:  NLM     Status:  Publisher    
Context:Relatively little is known in euthyroid populations about the changes in maternal thyroid hormones during pregnancy, the nature of the relationship to cord thyroid hormone levels, and subsequent infant neurodevelopment.Objectives:The aim of the study was to describe the relationship between maternal and cord thyroid hormone parameters and to describe their associations with neurodevelopment at 5.5 years.Design:We conducted a follow-up of women and their children born at or over 37 weeks' gestation.Main Outcomes:We measured maternal levels of TSH, thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TgAb), T(4), and free T(4) (FT(4)) at 10 and 34 weeks and at delivery, and cord levels of T(4), FT(4), TPOAb, and TgAb. The association of cord thyroid hormone parameters with McCarthy scale scores adjusted for the major confounders of neurodevelopment.Results:Fifteen percent of the women were TPOAb-positive, and 12% were TgAb-positive; the proportion of women with mildly elevated TSH levels increased during pregnancy with the maximum (14%) at delivery. Lower perceptual performance and motor scores were found with TgAb-positive women and lower perceptual performance scores with TgAb-positive cord levels; otherwise, unadjusted maternal levels of TPOAb, TgAb, and TSH and unadjusted cord levels of FT(4), TPOAb, and TgAb were not associated with neurodevelopment at 5.5 years. Low cord T(4) levels were associated with significant increments in four McCarthy scales: General Cognitive Index, Verbal, Quantitative, and Memory scales-increments that persisted after adjustment at 11.4, 7.8, 7.6, and 7.8 points, respectively.Conclusions:Lower levels of cord T(4) were associated with increments in the McCarthy scales in the domains that tested cognitive and verbal abilities at 5.5 years.
Fiona L R Williams; Jennifer Watson; Simon A Ogston; Theo J Visser; Robert Hume; Peter Willatts
Related Documents :
15980647 - Antenatal treatment of chylothorax and cystic hygroma with ok-432 in nonimmune hydrops ...
17252527 - First-trimester treatment of fetal anemia secondary to parvovirus b19 infection.
9572167 - Aplastic anemia and immune-mediated thrombocytopenia: concurrent complications encounte...
927767 - Successful management of pregnancy-induced pancytopenia.
15750007 - Non-invasive fetal rhd and rhce genotyping using real-time pcr testing of maternal plas...
14686527 - The diversification of halenia (gentianaceae): ecological opportunity versus key innova...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-15
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  -     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Population Health Sciences (F.L.R.W., J.W., S.A.O., R.H.), University of Dundee, Ninewells Hospital and Medical School Campus, Dundee DD2 4BF, Scotland; Department of Internal Medicine (T.J.V.), Erasmus University Medical Centre, 3015 GE Rotterdam, The Netherlands; and Department of Psychology (P.W.), University of Dundee, Dundee DD1 4HN, Scotland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Disease severity and radioactive iodine use for thyroid cancer.
Next Document:  Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstruc...